1. Activates macrophages, which can attack and destroy cancer cells.
2. Reduces tumor size by inhibiting cancer cell growth.
3. Enhances the body’s immune response to target and eliminate cancer cells.
4. Prevents the formation of new blood vessels that supply nutrients to tumors.
5. Induces programmed cell death in cancer cells, helping to reduce tumor mass.
6. Converts tumor-associated macrophages from a pro-tumor to an anti-tumor state.
7. Limits the spread of cancer cells to other parts of the body.
8. Improves the effectiveness of chemotherapy by making cancer cells more susceptible to treatment.
9. Lowers inflammation in the tumor microenvironment, which can inhibit cancer growth.
10. Has the ability to reduce cancer-related symptoms and improve overall quality of life for patients.
11. Aids in the removal of cancer cell debris and toxins from the body.
12. Increases the ability of macrophages to engulf and digest cancer cells.
13. Lowers the overall number of cancer cells in the body.
14. Helps the immune system recognize and target cancer cells more effectively.
15. GcMaf is well-tolerated and has minimal side effects and no known long term effects compared to conventional cancer treatments.

These potential benefits highlight the importance of GcMAF in the treatment of cancerous teratoma masses.